Gross margin moved 137 bp higher
Gross margin changed +137 basis points from the comparable as-filed period.
72.23%→73.60%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PEGA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 1319 bp lower
Free-cash-flow margin changed -1319 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
13.59%→0.40%2 prior comparisons
Operating cash-flow margin moved 1322 bp lower
Operating cash-flow margin changed -1322 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
14.76%→1.54%2 prior comparisons
Receivables / revenue moved 912 bp lower
Receivables / revenue changed -912 basis points from the comparable as-filed period.
42.20%→33.08%2 prior comparisons
Stock-based compensation decreased 33.4%
Stock-based compensation changed -33.4% from the comparable as-filed period.
$43.0M→$28.7M2 prior comparisons
Operating margin moved 2 bp lower
Operating margin changed -2 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.79%→3.78%2 prior comparisons
Working capital / assets moved 1471 bp lower
Working capital / assets changed -1471 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
16.58%→1.87%4 prior comparisons
Current assets decreased 13.3%
Current assets changed -13.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$811.8M→$703.9M4 prior comparisons
Revenue increased 3.1%
Revenue changed +3.1% from the comparable as-filed period.
$381.4M→$393.4M2 prior comparisons
Current liabilities increased 13.6%
Current liabilities changed +13.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$597.5M→$679.0M4 prior comparisons
Operating income increased 2.7%
Operating income changed +2.7% from the comparable as-filed period.
$14.5M→$14.9M2 prior comparisons
Current ratio decreased 23.7%
Current ratio changed -23.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.36→1.044 prior comparisons
Research & development decreased 5.6%
Research & development changed -5.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$78.8M→$74.3M2 prior comparisons
R&D / revenue moved 176 bp lower
R&D / revenue changed -176 basis points from the comparable as-filed period.
20.65%→18.89%2 prior comparisons
Shares outstanding decreased 3.6%
Shares outstanding changed -3.6% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
169,722,783→163,663,5458 prior comparisons
Gross profit increased 5.1%
Gross profit changed +5.1% from the comparable as-filed period.
$275.5M→$289.5M2 prior comparisons
Total assets increased 2.9%
Total assets changed +2.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.3B→$1.3B4 prior comparisons
Capex / revenue moved 3 bp lower
Capex / revenue changed -3 basis points from the comparable as-filed period.
1.17%→1.15%2 prior comparisons
Cost of revenue decreased 1.9%
Cost of revenue changed -1.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$105.9M→$103.8M2 prior comparisons
Capital expenditure increased 0.8%
Capital expenditure changed +0.8% from the comparable as-filed period.
$4.5M→$4.5M2 prior comparisons
Operating margin moved 54 bp lower
Operating margin changed -54 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.49%→3.95%2 prior comparisons
Revenue increased 9.4%
Revenue changed +9.4% from the comparable as-filed period.
$384.5M→$420.7M2 prior comparisons
Capital expenditure increased 98.6%
Capital expenditure changed +98.6% from the comparable as-filed period.
$2.1M→$4.2M3 prior comparisons
Receivables / revenue moved 665 bp lower
Receivables / revenue changed -665 basis points from the comparable as-filed period.
40.69%→34.04%2 prior comparisons
Current liabilities increased 20.0%
Current liabilities changed +20.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$599.6M→$719.3M4 prior comparisons
Free-cash-flow margin moved 245 bp lower
Free-cash-flow margin changed -245 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
21.88%→19.43%2 prior comparisons
Working capital / assets moved 1551 bp lower
Working capital / assets changed -1551 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
18.57%→3.07%4 prior comparisons
Free-cash-flow proxy decreased 2.9%
Free-cash-flow proxy changed -2.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$84.1M→$81.7M3 prior comparisons
Operating income decreased 3.7%
Operating income changed -3.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$17.3M→$16.6M2 prior comparisons
Operating cash-flow margin moved 200 bp lower
Operating cash-flow margin changed -200 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
22.44%→20.44%2 prior comparisons
Operating cash flow decreased 0.3%
Operating cash flow changed -0.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$86.3M→$86.0M3 prior comparisons
Shares outstanding decreased 3.9%
Shares outstanding changed -3.9% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
171,080,665→164,404,9458 prior comparisons
Gross profit increased 13.7%
Gross profit changed +13.7% from the comparable as-filed period.
$274.9M→$312.7M2 prior comparisons
Current ratio decreased 24.9%
Current ratio changed -24.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
1.41→1.064 prior comparisons
SBC / revenue moved 94 bp lower
SBC / revenue changed -94 basis points from the comparable as-filed period.
9.55%→8.61%2 prior comparisons
Research & development increased 6.8%
Research & development changed +6.8% from the comparable as-filed period.
$78.8M→$84.2M2 prior comparisons
Current assets decreased 9.9%
Current assets changed -9.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$845.6M→$761.7M4 prior comparisons
Cash & equivalents decreased 8.2%
Cash & equivalents changed -8.2% from the comparable as-filed period.
$201.6M→$185.1M2 prior comparisons
Trade receivables decreased 8.5%
Trade receivables changed -8.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$156.5M→$143.2M4 prior comparisons
Capex / revenue moved 45 bp higher
Capex / revenue changed +45 basis points from the comparable as-filed period.
0.56%→1.01%2 prior comparisons
Total assets increased 4.5%
Total assets changed +4.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.3B→$1.4B4 prior comparisons
R&D / revenue moved 48 bp lower
R&D / revenue changed -48 basis points from the comparable as-filed period.
20.49%→20.01%2 prior comparisons
Cost of revenue decreased 1.4%
Cost of revenue changed -1.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$109.6M→$108.0M2 prior comparisons
Stock-based compensation decreased 1.4%
Stock-based compensation changed -1.4% from the comparable as-filed period.
$36.7M→$36.2M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.